BALT names new CEO of BALT International

French medical device company BALT has hired industry veteran Pascal Girin to be the new CEO of BALT International.

Girin worked at vascular device manufacturer ev3 from 2003 to 2010, holding a number of executive positions, and he has also worked at Baxter, Keystone Dental, and Wright Medical Technology.

“Thanks to the quite unique innovation DNA of the founding family, BALT has the best and widest product range in the sector” Girin said in a prepared statement. “Our duty is to bring BALT’s products to practitioners across the globe, allowing them to treat ever more complex cases. I am very enthusiastic about the growth potential of the group.”

“I am pleased to welcome Pascal in the team,” Nicolas Plowiecki, BALT president, said in the statement. “We have known and respected each other for a decade and I am sure that Pascal will perfectly fit with the culture of the Group. The Neurovascular industry is facing an unprecedented level of innovation and growth. Pascal comes with tremendous strategic and industry experience to guide the group’s development across the world, giving it the means to address the strong demand from our customers.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.